CONMED | CNMD - Debt


CONMED reported $834.25M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
3M USD 15B 2.45B Sep/2026
Abbott USD 34.05B 20.19B Mar/2026
Accuray USD 170.24M 4.52M Sep/2024
AtriCure USD 71.05M 736K Jun/2026
Baxter International USD 9.67B 20M Jun/2026
Becton, Dickinson and Co. USD 16.81B 471M Jun/2026
Boston Scientific USD 12.62B 1.6B Jun/2026
CONMED USD 834.25M 26.62M Jun/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dexcom USD 1.24B 154.7M Sep/2026
Edwards Lifesciences USD 598.8M 105.6M Sep/2026
Globus Medical USD 111.19M 4.03M Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 962.1M 13.7M Sep/2026
Integra LifeSciences USD 2.05B 9.43M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 49.04B 5.95B Jun/2026
Medtronic USD 28.15B 192M Jun/2026
Merit Medical Systems USD 820.12M 1.44M Jun/2026
Olympus JPY 336.52B 102.64B Sep/2026
Orthofix International USD 137.23M 338K Sep/2024
ResMed USD 825.92M 17.25M Jun/2026
Steris USD 2.04B 42.7M Jun/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teleflex USD 2.87B 186.84M Jun/2026
Zimmer Biomet Holdings USD 7.5B 25.2M Sep/2026